Monti Jaime M, Jantos Héctor
Department of Pharmacology and Therapeutics, Clinics Hospital, 2833/602 Zudañez Street, Montevideo 11300, Uruguay.
Behav Brain Res. 2006 Feb 28;167(2):245-50. doi: 10.1016/j.bbr.2005.09.025. Epub 2005 Nov 11.
The effects of SB-269970, a selective 5-HT(7) receptor antagonist, on spontaneous sleep were studied in adult rats implanted for chronic sleep recordings. SB-269970 was infused directly into the dorsal raphe nucleus (DRN) during the light phase. The 5-HT(7) receptor antagonist (0.25-1.0 mM) induced a significant reduction of REM sleep and of the number of REM periods whereas REM sleep latency was augmented. Pretreatment with the GABA(A) receptor agonist muscimol (1.0-2.0 mM), which by itself did not affect sleep variables, prevented the decrease of REM sleep induced by SB-269970 (1.0 mM). Our results indicate that the 5-HT(7) receptor is involved in the effect of DRN serotonergic (5-HT) neurons on brainstem structures that act to promote and induce REM sleep. We propose that the SB-269970-induced suppression of REM sleep is dependent upon the inhibition of GABA release in the DRN.
在植入用于慢性睡眠记录的成年大鼠中,研究了选择性5-羟色胺(5-HT)7受体拮抗剂SB-269970对自发睡眠的影响。在光照期将SB-269970直接注入中缝背核(DRN)。5-HT7受体拮抗剂(0.25 - 1.0 mM)可显著减少快速眼动睡眠(REM睡眠)和REM睡眠周期的数量,而REM睡眠潜伏期延长。用γ-氨基丁酸A(GABA(A))受体激动剂蝇蕈醇(1.0 - 2.0 mM)进行预处理,其本身不影响睡眠变量,但可防止SB-269970(1.0 mM)诱导的REM睡眠减少。我们的结果表明,5-HT7受体参与了DRN中5-羟色胺能(5-HT)神经元对脑干结构的作用,这些脑干结构可促进和诱导REM睡眠。我们提出,SB-269970诱导的REM睡眠抑制取决于DRN中GABA释放的抑制。